Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2007-01-30
2007-01-30
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C554S053000, C514S020800, C514S631000, C548S336500, C530S327000, C530S328000
Reexamination Certificate
active
10318278
ABSTRACT:
Transport reagents and conjugates of therapeutic agents linked to transport reagents are described. In particular, the transport reagents have a plurality of guanidinium moieties that are either contiguous or spaced along a backbone, but are sufficiently removed from the backbone via tethers, to allow their interaction with a cell or tissue surface, leading to uptake of the therapeutic agent.
REFERENCES:
patent: 4004074 (1977-01-01), Gerecht et al.
patent: 5053326 (1991-10-01), Renz
patent: 5723496 (1998-03-01), Nakada
patent: 5824474 (1998-10-01), Matsuhisa et al.
patent: 6251433 (2001-06-01), Zuckermann et al.
patent: 6464971 (2002-10-01), Matthews et al.
patent: 6534639 (2003-03-01), Manoharan et al.
patent: 6642365 (2003-11-01), Lapidot et al.
patent: 6669951 (2003-12-01), Rothbard et al.
patent: 6730293 (2004-05-01), Rothbard et al.
patent: 2002/0127198 (2002-09-01), Rothbard et al.
patent: 2003/0032593 (2003-02-01), Wender et al.
patent: WO 98/52614 (1998-11-01), None
patent: WO 01/13957 (2001-03-01), None
Fuchs et al. (2001), “Effect of Guanidinium Display on the Translocation of Molecules through Membranes,”Abstracts of Papers American Chemical Society 222(1-2), abstract only.
Rothbard et al. (2002), “Arginine-Rich Molecular Transporters for Drugs: The Roles of Backbone and Side Chain Variations on Cellular Uptake,” Cell-Penetrating Peptides, Chapter 7, pp. 141-160.
Wender et al. (2000), “The Design, Synthesis, and Evaluation of Molecules that Enable or Enhance Cellular Uptake: Peptoid Molecule Transporters,”PNAS 97(24):13003-13008.
Wender et al. (2002), “Oligocarbamate Molecular Transporters: Design, Synthesis, and Biological Evaluation of a New Class of Transporters for Drug Delivery,” J. Am. Chem. Soc. 124(45):13382-13383.
Wright et al. (2003), “Guanidinium Rich Peptide Transporters and Drug Delivery,”Current Protein and Peptide Science 4(2):105-124.
Jessop Theodore C.
Pattabiraman Kanaka
Pelkey Erin T.
Rothbard Jonathan B.
Wender Paul A.
Cellgate, Inc.
Lukton David
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Guanidinium transport reagents and conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidinium transport reagents and conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidinium transport reagents and conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3721490